Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1998
05/22/1998CA2271951A1 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof
05/22/1998CA2271788A1 Analogs of peptide yy and uses thereof
05/22/1998CA2271784A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
05/22/1998CA2271777A1 Hsv/aav hybrid amplicon vectors
05/22/1998CA2271774A1 Helicobacter polypeptides and corresponding polynucleotide molecules
05/22/1998CA2271734A1 Tgf.beta.1-responsive cells from bone marrow
05/22/1998CA2271718A1 Genes encoding telomerase proteins
05/22/1998CA2271699A1 Chimeric ltb vaccines
05/22/1998CA2271696A1 Morphogen peptide-induced regeneration of sense perceptory tissues
05/22/1998CA2271464A1 Conditioning for allogeneic stem cell transplantation
05/22/1998CA2271100A1 Treatment of diabetes with transcription factor gene
05/22/1998CA2270985A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998CA2270910A1 Glutathione s-transferase (gst) genes in cancer
05/22/1998CA2270908A1 Connective tissue growth factor-3
05/22/1998CA2270875A1 Nucleic acid encoding schwannomin-binding-proteins and products related thereto
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/22/1998CA2270772A1 Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome
05/22/1998CA2270766A1 Pretraumatic use of hemoglobin
05/22/1998CA2270634A1 Methods and compositions for stimulating neurite growth
05/22/1998CA2270629A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998CA2270546A1 Aids remedy
05/22/1998CA2270158A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
05/22/1998CA2270156A1 Human breast tumor-specific proteins
05/22/1998CA2269636A1 C3 binding protein of streptococcus pneumoniae
05/22/1998CA2268018A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/22/1998CA2263148A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof
05/22/1998CA2242384A1 Exodus chemokine materials and methods
05/22/1998CA2242335A1 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
05/21/1998CA2216616A1 Cayae1
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0843012A2 Biosynthetic gene murG from streptococcus pneumoniae
05/20/1998EP0843011A2 RsbU-1 derived from Staphylococcus
05/20/1998EP0843009A2 A human mytrophin clone hsabh01
05/20/1998EP0842948A1 ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME
05/20/1998EP0842947A2 Hepatitis C virus asialoglycoproteins
05/20/1998EP0842946A1 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842666A2 Combined use of anti-endotoxin synthetic peptides and of anti-endotoxin antibodies for the prophylaxis and treatment of endotoxicosis and septic shock
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842433A1 Materials and methods for detection of breast cancer
05/20/1998EP0842297A1 Methods of predicting the outcome of infection
05/20/1998EP0842284A1 Recombinant protein having bacteriophage endosialidase enzymatic activity
05/20/1998EP0842282A1 Alfa-beta c4bp-type recombinant heteromultimeric proteins
05/20/1998EP0842281A1 Peptide analog inhibitors of urokinase receptor activity
05/20/1998EP0842278A1 Dnase-active protein
05/20/1998EP0842276A1 Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
05/20/1998EP0842275A1 PRODUCTION OF BIOLOGICALLY ACTIVE RECOMBINANT BOVINE FOLLICLE STIMULATING HORMONE (REC bFSH) IN THE BACULOVIRUS EXPRESSION SYSTEM
05/20/1998EP0842274A1 Human mp52 arg protein
05/20/1998EP0842273A2 Receptor ligand vegf-c
05/20/1998EP0842272A1 Novel receptor ligands and genetic sequences encoding same
05/20/1998EP0842269A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842267A1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME
05/20/1998EP0842209A2 Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842195A1 Peptide inhibitors of fibronectine
05/20/1998EP0842194A1 Chimeric receptor molecules for delivery of co-stimulatory signals
05/20/1998EP0842193A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
05/20/1998EP0842192A2 Antimicrobial cationic peptides
05/20/1998EP0842191A2 Cyclosporin derivatives with anti-hiv activity
05/20/1998EP0842189A1 Early onset alzheimer's disease gene and gene products
05/20/1998EP0842186A1 Cross-linking oligonucleotides
05/20/1998EP0841946A1 Methods for treatment of allergic asthma
05/20/1998EP0841939A1 Therapeutic agents and autoimmune diseases
05/20/1998EP0841938A1 Treatment of acute leukemia with interleukin-10
05/20/1998EP0841937A1 Use of betaglycan to reduce scarring
05/20/1998EP0841935A1 Modulation of endothelial cell proliferation
05/20/1998EP0841933A1 Bowman-birk inhibitor compositions for treatment of imflammatory disease
05/20/1998EP0841932A1 Drug delivery enhancement via modified saponins
05/20/1998EP0841930A1 Stable solid formulation of enalapril salt and process for preparation thereof
05/20/1998EP0841918A1 Thrombin inhibitors
05/20/1998EP0841917A1 Method of treatment for exercise-induced pulmonary hemorrhage in racing stock
05/20/1998EP0841914A2 Use of griseofulvin for inhibiting the growth of cancers
05/20/1998EP0824545A4 Peptide compositions with growth factor-like activity
05/20/1998EP0745091A4 Use of angiotensin ii analogs in tissue repair
05/20/1998EP0597997B1 Lanthionine bridged peptides
05/20/1998EP0546076B1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK
05/20/1998EP0542860B1 Immunosuppressive compositions
05/20/1998EP0463053B1 Production and use of anthelmintic agents and protective immunogens
05/20/1998EP0383799B1 Adheson variants
05/20/1998DE19647853A1 Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität Compounds with improved cartilage and / or osteoinductive activity
05/20/1998CN1182454A DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
05/20/1998CN1182453A MPL Ligand analogs
05/20/1998CN1182452A Osteoprotegerine
05/20/1998CN1182436A Thrombin inhibitors based on the amino acid sequence of hirudin
05/20/1998CN1182435A Casein Phosphopeptide, casein containing same and process for the preparation thereof
05/20/1998CN1182434A Novel peptide derivatives
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1182366A Use of nitric oxide donors or nitric oxide inhibitors for regulation cervical dilatation and extensiblity
05/20/1998CN1182364A Medicament form for delivery of collagenase to wounds and process for preparation thereof
05/20/1998CN1181975A Injection for varicose vein
05/20/1998CN1181974A Stabilized albumin-free recombinant factor VIII preparation having low sugar content
05/20/1998CN1181935A 抗氧化剂抑制剂 Antioxidants inhibitors
05/19/1998US5753790 Antidiabetic agents
05/19/1998US5753713 Method for promoting hair growth
05/19/1998US5753702 Inhibitors of neutrophil adhesion, antiinflammatory
1 ... 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 ... 3163